Application of Implantable Hemodynamic Monitoring in the Management of Patients With Diastolic Heart Failure: A Subgroup Analysis of the COMPASS-HF Trial

Journal of Cardiac Failure

Volumn 14, Issue 10, 2008, Pages 816-823

  Zile, Michael R ^a   Bourge, Robert C ^b   Bennett, Tom D ^c   Stevenson, Lynne Warner ^d   Cho, Yong K ^c   Adamson, Philip B ^e   Aaron, Mark F ^f   Aranda Jr , Juan M ^g   Abraham, William T ^h   Smart, Frank W ⁱ   Kueffer, Fred J ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c MEDTRONIC INC   (United States)

^d HARVARD UNIVERSITY   (United States)

^e UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^f SAINT THOMAS HOSPITAL   (United States)

^g UNIVERSITY OF FLORIDA   (United States)

^h OHIO STATE UNIVERSITY   (United States)

ⁱ MORRISTOWN MEMORIAL HOSPITAL   (United States)

Author keywords

Diastolic heart failure; hemodynamic monitor; left ventricle

Indexed keywords

ADULT; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC HEART FAILURE; EVALUATION; FEMALE; HEMODYNAMIC MONITORING; HOSPITALIZATION; HUMAN; IMPLANT; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MONITOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; COHORT STUDIES; DISEASE MANAGEMENT; FEMALE; HEART FAILURE, DIASTOLIC; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PROSTHESES AND IMPLANTS;

EID: 56549102669     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2008.07.235     Document Type: Article

References (34)

1. Fonarow G.C., and ADHERE Scientific Advisory Committee. The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med 4 Suppl 7 (2003) S21-S30
2. Yancy C.W., Lopatin M., Stevenson L.W., De Marco T., and Fonarow G.C. ADHERE Scientific Advisory Committee and Investigators. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 47 (2006) 76-84
3. Adams Jr. K.F., Fonarow G.C., Emerman C.L., LeJemtel T.H., Costanzo M.R., Abraham W.T., et al. ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149 (2005) 209-216
4. Yusuf S., Pfeffer M.A., Swedberg K., Granger C.B., Held P., McMurray J.J., et al. CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362 9386 (2003) 777-781
5. Ahmed A., Rich M.W., Fleg J.L., Zile M.R., Young J.B., Kitzman D.W., et al. Effects of digoxin on morbidity and mortality in diastolic heart failure: the Ancillary Digitalis Investigation Group Trial. Circulation 114 (2006) 397-403
6. Cleland J.G., Tendera M., Adamus J., Freemantle N., Polonski L., Taylor J., and PEP-CHF Investigators. The Perindopril in Elderly People with Chronic Heart Failure (PEP-CHF) study. Eur Heart J 19 (2006) 2338-2345
7. Carson P., Massie B.M., McKelvie R., McMurray J., Komadja M., Zile M.R., et al. I-PRESERVE investigators. The Irbesartan in heart failure with Preserved systolic function (I-PRESERVE) trial: rationale and design. J Card Fail 11 8 (2005) 576-585
8. Trial of Aldosterone Antagonist Therapy in Adults with Preserved Ejection Fraction Congestive Heart Failure (TOPCAT). Available online at www.clinicaltrials.gov, identifier NCT00094302
9. Aurigemma G.P., and Gaasch W.H. Clinical practice. Diastolic heart failure. N Engl J Med 351 (2004) 1097-1105
10. Owan T.E., Hodge D.O., Herges R.M., et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355 (2006) 251-264
11. Kitzman D.W., Little W.C., Brubaker P.H., Anderson R.T., Hundley W.G., Marburger C.T., et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 288 (2002) 2144-2150
12. Zile M.R., and Brutsaert D.L. New concepts in diastolic dysfunction and diastolic heart failure: part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 105 (2002) 1387-1393
13. Klapholz M., Maurer M., Lowe A.M., Messineo F., Meisner J.S., Mitchell J., et al. New York Heart Failure Consortium. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. J Am Coll Cardiol 43 (2004) 1432-1438
14. Smith G.L., Masoudi F.A., Vaccarino V., Radford M.J., and Krumholz H.M. Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. J Am Coll Cardiol 41 (2003) 1510-1518
15. Curtis J.P., Sokol S.I., Wang Y., Rathore S.S., Ko D.T., Jadbabaie F., et al. The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure. J Am Coll Cardiol 42 (2003) 736-742
16. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112 (2005) e154-e235
17. Swedberg K., Cleland J., Dargie H., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
18. Heart Failure Society of America. Executive summary: HFSA 2006 comprehensive heart failure practice guideline. J Card Fail 12 (2006) 10-38
19. Quiñones M.A., Zile M.R., and Massie B.M. Kass DA, for the Participants of the Dartmouth Diastole Discourses. Chronic heart failure: a report from the Dartmouth Diastole Discourses. Congest Heart Fail 12 (2006) 162-265
20. Stevenson LW, for the ESCAPE Investigators. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness. The ESCAPE Trial. JAMA 294 (2005) 1625-1633
21. Nohria A., Shah M.R., Stebbins A., Hill J.A., Abraham W.T., Frantz R.P., et al. Effect of empiric versus pulmonary artery catheter guided therapy on renal function in patients hospitalized with decompensated heart failure. Circulation 112 Suppl 2 (2005) abstract 3017
22. Reimold S., Tasissa G., Hamilton M.A., Bourge R.C., DiSalvo T.G., Elkayam U., et al. Greater reduction in mitral regurgitation during therapy guided by measured filling pressures. [abstract]. J Am Coll Cardiol 47 (2006) 1008-1094
23. Steinhaus D.M., Lemery R., Bresnahan Jr. D.R., Handlin L., Bennett T., Moore A., et al. Initial experience with an implantable hemodynamic monitor. Circulation 93 (1996) 745-752
24. Magalski A., Adamson P., Gadler F., Böhm M., Steinhaus D., Reynolds D., et al. Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: a multicenter 12-month follow-up study of patients with chronic heart failure. J Card Fail 8 (2002) 63-70
25. Ohlsson A., Kubo S.H., Steinhaus D., Connelly D.T., Adler S., Bitkover C., et al. Continuous ambulatory monitoring of absolute right ventricular pressure and mixed venous oxygen saturation in patients with heart failure using and implantable haemodynamic monitor: results of a 1 year multicentre feasibility study. Eur Heart J 22 (2001) 942-954
26. Braunschweig F., Linde C., Eriksson M.J., Hofman-Bang C., and Rydén L. Continuous hemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure. Eur Heart J 23 (2002) 59-69
27. Adamson P.B., Magalski A., Braunschweig F., Böhm M., Reynolds D., Steinhaus D., et al. Ongoing right ventricular hemodynamics in heart failure. Clinical value of measures derived from an implantable monitoring system. J Am Coll Card 41 (2003) 565-571
28. Bourge R.C., Abraham W.T., Adamson P.B., Aaron M.F., Aranda Jr. J.M., Magalski A., et al. Randomized controlled trial of an implantable hemodynamic monitor in advanced heart failure: the Chronicle Implantable Hemodynamic Monitor Offers Management to Patients with Advanced Signs and Symptoms of Heart Failure (COMPASS-HF) trial. J Am Coll Cardiol 51 (2008) 1073-1079
29. Reynolds D.W., Bartelt N., Taepke R., and Bennett T.D. Measurement of pulmonary artery diastolic pressure from the right ventricle. J Am Coll Cardiol 25 (1995) 1176-1182
30. Ohlsson A., Bennett T., Nordlander R., Rydén J., Astrom J., and Rydén L. Monitoring of pulmonary arterial diastolic pressure through a right ventricular pressure transducer. J Card Fail 1 (1995) 161-168
31. Chuang P.P., Wilson R.F., Homans D.C., Stone K., Bergman T., Bennett T.D., et al. Measurement of pulmonary artery diastolic pressure from a right ventricular pressure transducer in patients with heart failure. J Card Fail 2 (1996) 41-46
32. Agresti A. Categorical data analysis (2002), John Wiley & Sons, Hoboken, NJ 559-563 2385-91
33. Stevenson L.W., and Perloff J.K. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 261 (1989) 884-888
34. Chakko S., Woska D., Martinez H., de Marchena E., Futterman L., Kessler K.M., et al. Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. Am J Med 90 (1991) 353-359